Definitive Contract W81XWH19C0077
Award Date
9/25/19
Potential Completion Date
12/24/21
Potential Value
$947K
Federal Agency
Medical Command
Awardee
Critical Innovations LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Inglewood, CA 90302, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,100,000.00 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of the Pleurapath Thoracostomy System, a medical device for military and pre-hospital healthcare applications. The contract is set to be completed by October 12, 2025. Critical Innovations LLC is a for-profit limited liability company that specializes in...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business focused on medical research and development. The $150,000.00 Firm Fixed Price contract is for research under the SBIR program. As a prime contractor, Critical Innovations has previously received over $10 million in SBIR contracts from various military agencies for the development of medical products including devices for wound...
This is a $1,550,000.00 Firm Fixed Price, Definitive Contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a for-profit limited liability company, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of the "BurRapid Intracranial Access Platform with QuickICP and QuickVentric Attachments" medical research and development project, with a total small business set-aside designation. Critical Innovations LLC is...
This is a $1,550,000.00 fixed-price level of effort contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company. The contract is for the Small Business Innovation Research (SBIR) Phase II project "DHA SBIR PHASE II O2-1681" and has a completion date of December 3, 2021. The contract is designated as a total small business set-aside. Critical Innovations, an ISO 13485:2016 certified medical research and development company,...
This is a firm fixed-price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,100,000.00, is for the development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control" as part of a Phase II SBIR effort. Critical Innovations LLC is an ISO certified, DCAA compliant medical research and development company that has been...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This federal contract award is for a Phase I Small Business Innovation Research (SBIR) effort by the Department of the Army Medical Command. The contract, valued at $167,500.00, was awarded to Critical Innovations LLC, a for-profit limited liability company focused on medical research and development. The contract is for the development of "Succor Combat Foam for Advanced Wound Care of Traumatized Tissue," which supports the Army's medical research and development efforts. As a Phase I...
This contract was awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business medical research and development company, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,300,000.00, is for the development of the "Donaldson Decompression Needle for Automated Treatment of Tension Pneumothorax" during SBIR Phase II. Critical Innovations specializes in advanced medical technologies for military and pre-hospital...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a limited liability company focused on medical research and development. The contract is for the development of the "Donaldson Decompression Needle for Automated Diagnosis and Treatment of Tension Pneumothorax," with a potential value of $162,499.98. The contract has a total small business set-aside designation, indicating it is reserved for small...
This is a $1,300,000.00 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company, for the development of the Succor Combat Foam for advanced wound care of traumatized tissue. The contract is part of the Small Business Innovation Research (SBIR) Program Phase II, with an ultimate completion date of December 11, 2026. The contract is designated as a total small business set-aside. Critical Innovations LLC is the...